Autoimmune & ArthritisResearch PaperPaywall

Shorter Telomeres and Depleted mtDNA Mark Rheumatoid Arthritis Lung Disease

RA patients with interstitial lung disease show accelerated cellular aging markers — shorter telomeres and fewer mitochondrial DNA copies than RA patients without lung involvement.

Wednesday, June 3, 2026 0 views
Published in Autoimmunity
A laboratory technician pipetting blood samples into PCR tubes on a lab bench, with a lung CT scan displayed on a lightbox in the background

Summary

A new study from the University of Rome found that rheumatoid arthritis patients who develop interstitial lung disease display significantly shorter telomeres and reduced mitochondrial DNA copy numbers compared to RA patients without lung complications and healthy controls. The worst telomere shortening occurred in patients with the Usual Interstitial Pneumonia pattern, a particularly aggressive form. Researchers also detected dysregulated expression of key regulatory genes — TERF1 was elevated while TFAM was decreased — suggesting that oxidative stress in the inflamed lung environment may be actively driving cellular senescence. These findings point to measurable biological aging signatures that could eventually serve as biomarkers for identifying RA patients at highest risk of developing serious lung disease.

Detailed Summary

Rheumatoid arthritis is far more than a joint disease. Up to 20–30% of RA patients develop interstitial lung disease, a serious complication that significantly worsens prognosis. Understanding the biological mechanisms that distinguish RA patients who develop lung involvement from those who do not is an urgent clinical priority — and this study takes a meaningful step in that direction by examining cellular senescence markers.

Researchers enrolled 85 RA patients — subdivided into those with ILD (RA-ILD) and those without (RA-NILD) — alongside 21 healthy controls. Using quantitative PCR, they measured relative telomere length, mitochondrial DNA copy number, and expression levels of two regulatory genes: TERF1 (a telomere-binding protein) and TFAM (a mitochondrial transcription factor essential for mtDNA maintenance).

The results were striking. All RA patients showed significantly shorter telomeres than healthy controls, but RA-ILD patients had the most pronounced shortening — particularly those with Usual Interstitial Pneumonia, the fibrotic subtype with the poorest survival. Both RA-ILD and RA-NILD groups showed significantly reduced mtDNA copy numbers relative to controls. On the gene expression side, TERF1 was upregulated across RA patients, while TFAM was downregulated — patterns consistent with compensatory stress responses and mitochondrial dysfunction.

The authors propose that chronic oxidative stress — a hallmark of RA-associated pulmonary inflammation — accelerates telomere attrition and mitochondrial depletion in lung tissue, pushing cells toward senescence faster than in RA patients without lung disease.

For clinicians, these findings raise the possibility that telomere length and mtDNA copy number could eventually serve as accessible blood-based biomarkers to flag RA patients at heightened risk for ILD development or progression. For researchers, they suggest that senolytic or mitochondria-targeted therapies could be worth exploring in this population. Caveats include the small sample size and cross-sectional design.

Key Findings

  • RA-ILD patients had significantly shorter telomeres than both healthy controls and RA patients without lung disease.
  • Usual Interstitial Pneumonia subtype showed the most severe telomere shortening among all RA groups.
  • Both RA subgroups had significantly reduced mitochondrial DNA copy numbers versus healthy controls.
  • TERF1 (telomere regulator) was upregulated and TFAM (mitochondrial regulator) was downregulated in all RA patients.
  • Oxidative stress from pulmonary inflammation may accelerate cellular senescence markers in RA-ILD patients.

Methodology

Cross-sectional study enrolling 85 RA patients (stratified by ILD presence) and 21 healthy controls. Relative telomere length, mtDNA copy number, and TERF1/TFAM gene expression were quantified via qPCR from blood samples. ILD diagnosis and subtyping were confirmed via imaging.

Study Limitations

The summary is based on the abstract only, as the full text was not accessible. The cross-sectional design prevents causal inference about whether cellular senescence precedes or follows ILD development. The sample size — particularly the control group of 21 — limits statistical power and generalizability.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.